TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m116.740209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

FOXF2 Reprograms Breast Cancer Cells Into Bone Metastasis Seeds

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Prognostic Significance of TP53 Alterations in Breast Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1993English

Rhein Induces Apoptosis in Human Breast Cancer Cells

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2012English

Breast Cancer Cells Exploit Normal Stromal Cells in the Tumor Microenvironment.

English

Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2019English

Role of Nip3 in Apoptosis and Chemoresponses of Breast Cancer Cells

2001English

Exosomes From Breast Cancer Cells Stimulate Proliferation and Inhibit Apoptosis of CD133+ Cancer Cells in Vitro

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

TP53 Upregulates Α‑smooth Muscle Actin Expression in Tamoxifen‑resistant Breast Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

TP53 Mutations Promote Immunogenic Activity in Breast Cancer

Journal of Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy